The Cigna Group (FRA:CGN) Other Financing: €-606 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CGN The Cigna Group FRA:CGN
60 GF Score
Price €256.10
GF Value €370.65
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is The Cigna Group Other Financing?

The Cigna Group FRA:CGN +0.87% 60 Other Financing is €-606 Mil as of Mar. 2026. GuruFocus rates FRA:CGN with a GF Score™ of 60/100 and a GF Value™ of €370.65 (Significantly Undervalued). The stock has 5 warning signs investors should review.

The Cigna Group's Other Financing for the three months ended in Mar. 2026 was €-189 Mil.

The Cigna Group's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €-606 Mil.

The Cigna Group Other Financing Historical Data

* Premium members only.

The historical data trend for The Cigna Group's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cigna Group Other Financing Chart

The Cigna Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.24 -74.58 -430.07 -392.51 -619.15

The Cigna Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -221.08 -155.19 -155.06 -106.75 -188.57
FRA:CGN
60GF Score
The Cigna Group FRA:CGN
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cigna Group Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-606 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-606 Mil mean?
The Cigna Group (FRA:CGN) has a Other Financing of €-606 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for The Cigna Group and its competitors.
Is The Cigna Group's Other Financing too high?
The Cigna Group's current Other Financing is €-606 Mil. Overall, The Cigna Group has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's Other Financing compare to ELV and HUM?
The Cigna Group's Other Financing of €-606 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Plans company?
A good Other Financing depends on the Healthcare Plans industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for The Cigna Group and its competitors. The Cigna Group's current Other Financing is €-606 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (FRA:CGN) is currently considered Significantly Undervalued. The stock's GF Value™ is €370.65, compared to a current price of €256.10 — trading 30.9% below its estimated fair value. The current Other Financing is €-606 Mil. The Cigna Group's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For The Cigna Group (FRA:CGN), the current Other Financing is €-606 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cigna Group (FRA:CGN) Overvalued in 2026?

Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued. The current stock price of €256.10 is trading 30.9% below its estimated GF Value™ of €370.65. GuruFocus considers The Cigna Group to be Significantly Undervalued.

Key valuation signals for FRA:CGN:

  • Other Financing: €-606 Mil
  • GF Value™: €370.65 vs. price of €256.10 (30.9% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the FRA:CGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
60GF Score

Get the complete analysis for FRA:CGN

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€256.10
Price
€370.65
GF Value